RIG
DNA icon

Renaissance Investment Group’s Ginkgo Bioworks DNA Stock Holding History

Renaissance Investment Group’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-778
Closed -$9.6K – 87
2024
Q2 		$9.6K Hold
778
– – ﹤0.01% 84
2024
Q1 		$36.1K Hold
778
– – 0.01% 86
2023
Q4 		$52.6K Sell
778
-25
-3% -$1.53K 0.01% 81
2023
Q3 		$58.1K Hold
803
– – 0.02% 77
2023
Q2 		$59.7K Hold
803
– – 0.02% 79
2023
Q1 		$42.7K Hold
803
– – 0.01% 82
2022
Q4 		$54.2K Hold
803
– – 0.02% 82
2022
Q3 		$80K Hold
803
– – 0.02% 84
2022
Q2 		$76K Hold
803
– – 0.02% 82
2022
Q1 		$100K Buy
803
+449
+127% +$87.4K 0.03% 83
2021
Q4 		$118K Hold
354
– – 0.03% 83
2021
Q3 		$164K Buy
+354
New +$172K 0.04% 80

Other funds holding DNA

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Renaissance Investment Group's DNA Position: Q3 2024 in Review

Renaissance Investment Group sold out of Ginkgo Bioworks (DNA) in Q3 2024, closing a stake of 778 shares — an estimated $9.6K sold.

Renaissance Investment Group first reported a position in DNA in Q3 2021 and held it in 12 quarters. The position peaked at $164K in Q3 2021. 159 funds tracked by Wall St. Rank hold DNA as of Q3 2024.

  • Renaissance Investment Group reported no remaining Ginkgo Bioworks position as of Q3 2024 after selling out during the quarter.
  • Renaissance Investment Group sold 778 Ginkgo Bioworks shares in Q3 2024, an estimated $9.6K.
  • Renaissance Investment Group first reported a position in Ginkgo Bioworks in Q3 2021 and held it in 12 quarters.
  • Renaissance Investment Group's Ginkgo Bioworks position peaked at $164K in Q3 2021.
  • 159 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q3 2024.

Based on Renaissance Investment Group's 13F filing for Q3 2024, filed 10 Oct 2024.